Database Query Results : , , IL23
IL23, Interleukin 23: Click to Expand ⟱
| Source: |
| Type: |
A heterodimeric cytokine composed of an IL-12B subunit and an IL-23A subunit. IL-23 is part of the IL-12 family of cytokines.
IL-23 is an inflammatory cytokine. IL-23 is overexpressed in a number of cancer types.
|
Scientific Papers found: Click to Expand⟱
*antiOx↑, *Inflam↓, *AntiAge↑, *AMPK↑, *SIRT1↑, *NF-kB↓, *mTOR↓, *NLRP3↓, *NADPH↓, *ROS↓, *COX2↓, *MCP1↓, *IL1β↓, *IL17↓, *IL23↓, *TNF-α↓, *MPO↓, *IL10↑, *lipid-P↓, *SOD↑, *Aβ↓, *p‑tau↓, *GSK‐3β↓, *CDK5↓, *TXNIP↓, *NRF2↑, *NQO1↑, *HO-1↑, *OS↑, *memory↑, *BDNF↑, *neuroP↑, *BACE↓, *AChE↓, *LDL↓,
BMD↑, Cartilage↑, IL17↓, IL22↓, IL23↓, IL28↓, CD4+↓, CD8+↓, LAMB3↑, COL4↓, THBS2↓, ITGA11↓, PPARγ↑, ACAA1↓, PLIN1↓, FABP4↓, PCK1↓, UCP1↓, TNF-α↓,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
UCP1↓, 1,
Core Metabolism/Glycolysis ⓘ
ACAA1↓, 1, FABP4↓, 1, PCK1↓, 1, PLIN1↓, 1, PPARγ↑, 1,
Migration ⓘ
Cartilage↑, 1, COL4↓, 1, ITGA11↓, 1, LAMB3↑, 1, THBS2↓, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↓, 1, IL17↓, 1, IL22↓, 1, IL23↓, 1, IL28↓, 1, TNF-α↓, 1,
Clinical Biomarkers ⓘ
BMD↑, 1,
Infection & Microbiome ⓘ
CD8+↓, 1,
Total Targets: 19
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, HO-1↑, 1, lipid-P↓, 1, MPO↓, 1, NQO1↑, 1, NRF2↑, 1, ROS↓, 1, SOD↑, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, LDL↓, 1, NADPH↓, 1, SIRT1↑, 1,
Proliferation, Differentiation & Cell State ⓘ
GSK‐3β↓, 1, mTOR↓, 1,
Migration ⓘ
CDK5↓, 1, TXNIP↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL10↑, 1, IL17↓, 1, IL1β↓, 1, IL23↓, 1, Inflam↓, 1, MCP1↓, 1, NF-kB↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BDNF↑, 1, p‑tau↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1, BACE↓, 1, NLRP3↓, 1,
Functional Outcomes ⓘ
AntiAge↑, 1, memory↑, 1, neuroP↑, 1, OS↑, 1,
Total Targets: 35
Scientific Paper Hit Count for: IL23, Interleukin 23
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:543 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page